$0.198
-0.005 (-2.65%)收盤時
價格預測
在 App 中開啟以解鎖更長週期的預測。
VTAK 相似圖表分析預測
Alphio's VTAK stock price prediction model matches the current Catheter Precision Inc tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $0.20 (+1.06%). The 1-week path is $0.21 (+3.92%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.
該買進 Catheter Precision Inc 股票嗎?
Given the current price of $0.20, a 90.01% year-to-date decline, and an RSI of 15.422 indicating oversold conditions, VTAK is not a good buy right now. The company has shown some positive revenue growth, but the overall financial health is concerning with a net income loss of $3.04 million in the latest quarter and a gross margin of 90.28%. The main risk is the substantial debt-to-equity ratio of 113.15%, indicating high leverage and financial instability.
VTAK 股價於 Tuesday 收在 $0.20,此前下跌 -2.65%
Catheter Precision Inc (VTAK) last closed at $0.1983, losing -2.65%. These facts feed the 1-day and 1-week VTAK price prediction above.
預測驅動因素
Catheter Precision Inc(VTAK)的預測驅動因素綜合了相似的圖表形態、季節性與移動平均線。
Similar patterns
Bullish
Seasonality
Bearish
SMA 20
Bearish
SMA 200
Bearish
相似圖表形態
近期走勢與 VTAK 最接近的股票,依相似度排序。
VTAK 季節性分析
Historically the probability of a positive September return for VTAK is 0.00%. January offers the highest probability of a positive month at 52.46%, while July is the weakest seasonal window. Alphio blends this calendar with technical signals and similar chart pattern matching before it writes the forecast.
本頁僅供研究參考,不構成投資建議。模型可能出錯。過往表現不代表未來結果。